Kasia Lipska is an Endocrinology/Metabolic physician affiliated with Yale University. OpenAlex indexes 202 publications with 7,518 citations (h-index 41); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
333 Cedar St
Yale University Med School/int Medicine (endocrine)
New Haven, CT 065103206
Telephone
203-737-4853Registry record last updated 17 Sept 2012.
Clinical trials
- Continuous Glucose Monitors (CGMs) for All: Studying the Impact of Expanding CGM Access
Sponsor: Yale University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
79.8%GLP-1 receptor agonist32.5%Ozempic56%Mounjaro44%Part D≥24 patientsInsulin Analog20.2%Lantus Solostar61%Novolog Flexpen20%Tresiba Flextouch U-20019%Part D<11 patients+ 3 more classes in this area
Hormonal (systemic)
11.6%l-Thyroxine11.6%Levothyroxine Sodium100%Part D<11 patientsCardiovascular
8.6%ACE inhibitor4.5%Lisinopril100%Part D<11 patientsStatin4.1%Rosuvastatin Calcium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
6 NIH research awards on record, funded 2013–2026 per NIH RePORTER. The latest:
- "Insulin Affordability: Unpacking the Impact of the Inflation Reduction Act on Diabetes Outcomes in Medicare."
Yale University
FY2026$692,186R01DK141666 - Addressing Social Determinants of Health in Young Adults with Type 1 Diabetes Through Comprehensive Assessment, Responsiveness, and Engagement (T1CARE)
Yale University
FY2026$468,180R01DK139558 - "Insulin Affordability: Unpacking the Impact of the Inflation Reduction Act on Diabetes Outcomes in Medicare."
Yale University
FY2025$818,883R01DK141666
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Realigning diabetes regimens in older adults: a 4S Pathway to guide simplification and deprescribing strategies
The Lancet Diabetes & Endocrinology
2025 - Contemporary National Patterns of Eligibility and Use of Novel Cardioprotective Antihyperglycemic Agents in Type 2 Diabetes Mellitus
Journal of the American Heart Association
2021 - Patterns of Prescribing Sodium-Glucose Cotransporter-2 Inhibitors for Medicare Beneficiaries in the United States
Circulation Cardiovascular Quality and Outcomes
2021
Similar KOLs
Other experts from the same institution or the same specialty.
John Krystal, MD
Yale University
Lajos Pusztai, MD
Yale University
Lee Schwamm, MD
Yale University
Naftali Kaminski, MD
Yale University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”